Skip to main content
. 1998 Jan;111(1):158–165. doi: 10.1046/j.1365-2249.1998.00448.x

Fig. 7.

Fig. 7

Direct binding of truncated peptide A analogues (250 μm) to B cell lines homozygous for HLA-DR3 and -DQ2, derived from coeliac disease patients. Binding is expressed as a percentage compared with binding of peptide A. The negative control is the HLA-negative K562 erythroleukaemic cell line.